BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JS Genetics Announces Launch of XCAT-KS, A Bloodless, Cheek Swab Test for the Diagnosis of Klinefelter Syndrome and Other Male Sex Chromosome Aneuploidies


5/3/2012 11:05:50 AM

NEW HAVEN, Conn., May 2, 2012 /PRNewswire/ -- JS Genetics announces the availability of XCAT-KS, its proprietary buccal swab test for the diagnosis of Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. Klinefelter syndrome, a condition in which males have an extra X chromosome, is one of the most common genetic abnormalities in males. It is estimated that about one in every 500 males has an extra X chromosome.

Klinefelter syndrome can affect physical development resulting in low muscle tone, infertility, gynecomastia and hypogonadism. KS can also result in language development disorders including delayed speech and social problems such as shyness and moody behavior. However, the diagnosis of KS is not readily apparent on physical exams or by routine testing. Only 25% of KS patients are diagnosed during their lifetime.

XCAT-KS is a PCR / pyrosequencing based test which identifies Klinefelter syndrome and other male sex chromosome aneuploidies with 100% sensitivity and specificity as detailed in a validation study published in the International Journal of Pediatric Endocrinology (2012:8 23 April 2012).

The results of the XCAT-KS will typically be available within 3 business days following receipt of the buccal swabs at JS Genetics' CLIA certified laboratory.

In other news, JS Genetics announces that it has been awarded re-accreditation by the College of American Pathologists (CAP). As part of the biannual re-accreditation program, CAP inspectors examine laboratory staff qualifications, as well as the laboratory's equipment, facilities and records, and the overall management of the laboratory. The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the US Federal government as being equal to or more stringent than the government's own inspection program and is designed to specifically ensure the highest standard of care for all laboratory patients.

About JS Genetics
JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. (CLIA ID# 07D1091103; CAP# 72115351)

For more information about JS Genetics or XCAT-KS visit www.jsgenetics.com. Physicians who would like to obtain testing kits at no charge can order at www.jsgenetics.com or call 1-888-217-8947.

SOURCE JS Genetics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES